Vaccines (Apr 2022)

Self-Reported COVID-19 Vaccine Hesitancy and Willingness to Pay: A Cross-Sectional Survey in Thailand

  • Kulpatsorn Mueangpoon,
  • Chapipak Inchan,
  • Panithan Kaewmuneechoke,
  • Peerunda Rattana,
  • Supanut Budsratid,
  • Suthasinee Japakiya,
  • Pitchayanont Ngamchaliew,
  • Polathep Vichitkunakorn

DOI
https://doi.org/10.3390/vaccines10040627
Journal volume & issue
Vol. 10, no. 4
p. 627

Abstract

Read online

This study aimed to estimate the prevalence and influencing factors of COVID-19 vaccine hesitancy and willingness to pay in Thailand. A descriptive cross-sectional study was conducted from 13 September 2021 to 14 January 2022. Data were collected using an online questionnaire consisting of demographic characteristics, COVID-19 vaccine hesitancy (delay in acceptance and denying vaccination), determinants of vaccine hesitancy (complacency, convenience, and confidence), and willingness to pay. The general Thai population aged ≥18 years were surveyed. Among 705 respondents, 10.4% reported hesitancy, with significant determinants being low complacency and confidence in the vaccine; low convenience was not a significant determinant. Multivariate analysis revealed vaccine hesitancy among women, those with higher education, non-healthcare workers, and those who lived in rural areas. Furthermore, 77.2% of respondents were willing to pay, with the majority willing to pay in the range of THB 501–1000 ( USD 1 = THB 33) per dose. Increased monthly income, no impact of COVID-19 on income, and time period (before mRNA vaccine availability) significantly affected willingness to pay.

Keywords